Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT02175121

Public ClinicalTrials.gov record NCT02175121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 4:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of Pf-06291874 Given As Monotherapy To Adults With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is going to assess the safety and tolerability of PF-06291874 in adults with Type 2 Diabetes Mellitus as monotherapy, to evaluate the significance of overall glycemic control in these subjects.

Study identification

NCT ID
NCT02175121
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
172 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2014 (Type not available)
Primary completion
Mar 2015 (Actual)
Completion
Mar 2015 (Actual)
Last update posted
Jun 15, 2016

2014 – 2015

United States locations

U.S. sites
19
U.S. states
10
U.S. cities
16
Facility City State ZIP Site status
Anaheim Clinical Trials, LLC Anaheim California 92801 —
Profil Institute for Clinical Research, Inc. Chula Vista California 91911 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Avail Clinical Research, LLC DeLand Florida 32720 —
SeaView Research, Inc. Miami Florida 33125 —
SeaView Research, Inc. Miami Florida 33126 —
Compass Research, LLC Orlando Florida 32806 —
Miami Research Associates, Inc. South Miami Florida 33143 —
MRA Clinical Research, LLC South Miami Florida 33143 —
MRA Clinical Research South Miami Florida 33143 —
Louisville Metabolic and Atherosclerosis Research Center Louisville Kentucky 40213 —
DaVita Clinical Research Minneapolis Minnesota 55404 —
Clinilabs, Inc. Eatontown New Jersey 07724 —
PRA International Marlton New Jersey 08053 —
Buffalo Clinical Research Center, LLC Buffalo New York 14202 —
High Point Clinical Trials Center, LLC High Point North Carolina 27265 —
Community Research Cincinnati Ohio 45255 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Rainier Clinical Research Center, Inc. Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02175121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 15, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02175121 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →